Geron Corporation (GERN)

Healthcare · Biotechnology · NASDAQ

Geron Corporation (GERN) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $1.01B and a free-cash-flow yield of -10.6%. Over the most recent reported fiscal year, revenue grew 138.8%.

Market cap	$1.01B
Trailing P/E	—
FCF yield	-10.6%
Revenue growth (YoY)	+138.8%
EPS growth (YoY)	—
FCF/share growth (YoY)	—
Exchange	NASDAQ
Sector	Healthcare
Industry	Biotechnology

Explore live GERN data on Nama Insights →